ZLAB Q4 2022 Earnings — Zai Lab Limited Revenue & Financial Results | Market Cap Arena

ZLABZai Lab Limited

$2B

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$63M+41.7% YoY

Gross Profit

$42M66.6% margin

Operating Income

-$97M-155.4% margin

Net Income

-$62M-98.7% margin

EPS (Diluted)

$-6.40

QoQ Revenue Growth

+8.8%

Cash Flow

Operating Cash Flow

-$109M

Free Cash Flow

-$114M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$175M

Stockholders' Equity

$1.0B

Cash & Equivalents

$1.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$63M	$44M	+41.7%
Gross Profit	$42M	-$150M	+127.9%
Operating Income	-$97M	-$219M	+55.6%
Net Income	-$62M	-$212M	+70.8%

Revenue Segments

Zejula

$42M68%

Optune

$12M20%

Qinlock

$6M9%

Nuzyra

$2M3%